| 注册
首页|期刊导航|中外医学研究|氨磺必利与阿立哌唑治疗首发精神分裂症对照研究

氨磺必利与阿立哌唑治疗首发精神分裂症对照研究

仇红杰

中外医学研究Issue(21):8-10,3.
中外医学研究Issue(21):8-10,3.

氨磺必利与阿立哌唑治疗首发精神分裂症对照研究

A Comparative Study of Amisulpride and Aripiprazole in the Treatment of First Episode Schizophrenia

仇红杰1

作者信息

  • 1. 南乐县精神病医院 河南 南乐 457400
  • 折叠

摘要

Abstract

Objective:To investigate the efficacy and safety of Amisulpride and Aripiprazole in the treatment of first episode schizophrenia. Method:75 patients of first opisode schizoprenia were randomly divided into two groups(amisulpride 37,aripiprazole 38).Both of the amisulpride and aripiprazole were administered to two groups respectively for 8 weeks. Their symptoms were assessed with PANSS and their side effects were assessed with TESS before and after the treatment. Result:The total cure rates were 89.19%in amisulpride group and 92.11%in aripiprazole group,with no significant difference between the two groups(P>0.05). PANSS score and each factor score in treatment of 4,6,8 weeks between the two groups had no statistical significance(P>0.05). Conclusion:Both of the amisulpride and aripiprazole have notable curative effect with less side-effect in the treatment of first episode schizophrenia.

关键词

氨磺必利/阿立哌唑/精神分裂症

Key words

Amisulpride/Aripiprazole/First episode schizophrenia

分类

医药卫生

引用本文复制引用

仇红杰..氨磺必利与阿立哌唑治疗首发精神分裂症对照研究[J].中外医学研究,2014,(21):8-10,3.

中外医学研究

1674-6805

访问量4
|
下载量0
段落导航相关论文